James Cross

James Cross is a distinguished figure in the biopharmaceutical industry, currently holding the position of Senior Vice President of Regulatory Affairs. He founded Cross BioStrategies LLC, where he also serves as the principal regulatory consultant. His extensive career includes roles such as Executive Director of Regulatory Affairs at Halozyme Therapeutics and Head of Regulatory Affairs at Forty Seven Inc. James began his industry career at Genentech, initially working in Drug Safety before moving to Oncology Regulatory Affairs. Prior to his industry roles, he spent five years at the FDA focusing on project management. Academically, James is well-qualified with a Ph.D. in health outcomes research from the University of Washington, an M.S. in immunology from the University of California at Davis, and a Bachelor’s degree in biology and French from Tufts University.